Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for NASDAQ stock OTLK Outlook Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.40 and Closed at: 0.43, which is 9.3% of previous session's close. It moved within a range of 0.38 and 0.44
The session was a Bullish session with an average volume of 1204100, which is -4.48% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.41 and resistance for tomorrow is 0.47
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.39, 0.36 resistance for tomorrow's hourly charts is 0.45, 0.48
10 Day SMA for Outlook Therapeutics (OTLK) is 0.44 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 0.49 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 1.23 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.26 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 1.52 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 0.49 and 200 DMA is at 1.52, while 50 DMA and 100 DMA are at 1.23 and 1.26 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.49 and 20 EMA is at 0.59
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 0.43 | 0.49 | 0.59 |
| 05 Thu Feb | 0.39 | 0.5 | 0.61 |
| 04 Wed Feb | 0.40 | 0.51 | 0.63 |
| 03 Tue Feb | 0.43 | 0.52 | 0.65 |
| 02 Mon Feb | 0.44 | 0.52 | 0.67 |
| 30 Fri Jan | 0.43 | 0.53 | 0.69 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 1.23 and 50 EMA is at 0.96
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 0.43 | 1.23 | 0.96 |
| 05 Thu Feb | 0.39 | 1.26 | 0.98 |
| 04 Wed Feb | 0.40 | 1.29 | 1 |
| 03 Tue Feb | 0.43 | 1.32 | 1.02 |
| 02 Mon Feb | 0.44 | 1.35 | 1.04 |
| 30 Fri Jan | 0.43 | 1.38 | 1.06 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 1.26 and 100 EMA is at 1.22
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 0.43 | 1.26 | 1.22 |
| 05 Thu Feb | 0.39 | 1.27 | 1.24 |
| 04 Wed Feb | 0.40 | 1.27 | 1.26 |
| 03 Tue Feb | 0.43 | 1.28 | 1.28 |
| 02 Mon Feb | 0.44 | 1.29 | 1.3 |
| 30 Fri Jan | 0.43 | 1.29 | 1.32 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 1.52 and 200 EMA is at 1.82
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 0.43 | 1.52 | 1.82 |
| 05 Thu Feb | 0.39 | 1.52 | 1.83 |
| 04 Wed Feb | 0.40 | 1.53 | 1.84 |
| 03 Tue Feb | 0.43 | 1.53 | 1.85 |
| 02 Mon Feb | 0.44 | 1.54 | 1.86 |
| 30 Fri Jan | 0.43 | 1.54 | 1.87 |
Xenon Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 25.34% more returns!
Rhythm Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 29.68% more returns!
Prothena Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Prothena Corporation, about 24.07% more returns!
Pulse Biosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 70.96% more returns!
Minerva Neurosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 34.99% more returns!
Endra Life has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Endra Life, about 10.78% more returns!
Mimedx Group has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Mimedx Group, about 11.55% more returns!
Moleculin Biotech has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 36.79% more returns!
Lemaitre Vascular has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 29.97% more returns!
Krystal Biotech has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Krystal Biotech, about 31.45% more returns!
Kodiak Sciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Kodiak Sciences, about 10.27% more returns!
Outlook Therapeutics has performed better than Biotelemetry Inc in short term. Holding Outlook Therapeutics could be a better choice for now!
Capricor Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 30.81% more returns!
Cellectar Biosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 25.82% more returns!
Dexcom Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 30.93% more returns!
Exelixis Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 26.8% more returns!
National Vision has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in National Vision, about 36.91% more returns!
Healthcare Services has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 27.59% more returns!
Iridex Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Iridex Corporation, about 54.08% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.45 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


